The close interaction between tumor cells and bone marrow stromal cells plays a crucial role in the tumorigenesis of multiple myeloma (MM). Reelin, an extracellular matrix protein, is found expressed in myeloma cells and is negatively associated with prognosis. We examined the role of Reelin in myeloma cell adhesion to bone marrow stromal cells and the signaling pathways involved. The results revealed that Reelin promoted the adhesion of myeloma cells to HS-5, a bone marrow stromal cell line, via the activation of β1 integrin. The resulting phosphorylation of focal adhesion kinase (FAK) led to the activation of Syk/STAT3 and Akt. Reelin's high affinity receptor ApoER2 indirectly modulated the adhesion of myeloma cells by promoting Reelin expression via Sp1. These findings indicate an important role for Reelin/integrin-β1-induced myeloma cell adhesion to bone marrow stromal cells and highlight the therapeutic potential of targeting Reelin/integrin/FAK axis.
Introduction
Multiple myeloma (MM) is a hematological malignancy characterized by clonal expansion of plasma cells within the bone marrow (BM). The behavior of myeloma cells such as tumor growth and drug resistance depends on the complex and reciprocal interactions of tumor cells with their BM microenvironment. Recent success in new classes of MM therapeutic agents is at least partially due to the fact that they can counteract certain aspects of MM-BM interactions (1) .
It is well known that adhesion of MM cells to bone marrow stromal cells (BMSCs) renders the tumor cells resistant against cytotoxic and apoptotic stimuli (2) (3) (4) (5) (6) (7) . It also contributes to complications of the disease including osteolysis and angiogenesis (8) (9) (10) . A variety of adhesive molecules, extracellular matrix (ECM), and soluble factors contribute to the adhesive interactions between MM cells and BMSCs. Identification of molecules involved in adhesion is critical for understanding MM biology and searching for novel therapeutic targets for this disease.
The extracellular matrix protein Reelin is an important regulator of proper migration and positioning of cortical neurons, differentiation of neuritis, and formation of spines and synapses during embryonic brain development (11) (12) (13) (14) (15) . The interaction of Reelin with its high affinity receptor apolipoprotein E receptor 2 (ApoER2) also promotes the adhesion of migrating neurons to fibronectin (FN) via "insideout" activation of integrin α5β1 (16) .
Reelin is also found in multiple types of tumors including prostate cancer, esophageal carcinoma, and
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International Publisher retinoblastoma (17) (18) (19) (20) . High Reelin level is reported to be associated with prostate cancer with high Gleason score (17) . Whether Reelin plays a similar role in promoting tumor cell adhesion to their microenvironment, including extracellular matrix or stromal cells is not clear. However, increased cell migration and colony formation was found in a pancreatic cancer cell line or esophageal carcinoma cell line that received siRNAs specific for Reelin, its receptors VLDLR and ApoER2, or the key adaptor Dab1. This suggests that Reelin may play a role in suppressing cell migration or promoting firm cell adhesion to components in the microenvironment (20) (21) .
We recently found Reelin expression in myeloma cells and the association of high Reelin expression with poor prognosis in myeloma patients (22) . We further found that Reelin promotes the adhesion of myeloma cells to FN-coated plates and protects the tumor cells from Doxorubicin-induced cell death. This MM cell-FN adhesion requires Dab1-independent activation of integrin β1 by Reelin. As the adhesion of MM cells to BMSCs is also mediated by the integrin family of adhesion molecules, we thus examined whether Reelin promotes the adhesion of myeloma cells to BMSCs and whether similar signaling pathway is involved.
Results

Reelin promotes MM cell adhesion to BMSCs
To examine the effect of Reelin on the adhesion of MM cells to BMSCs, two human myeloma cell lines, H929 and U266 that secret Reelin were used. CR-50, a function-blocking anti-Reelin antibody that blocks Reelin-Reelin homopolymer formation was added to H929 cells to suppress the intrinsic Reelin activity (23) . One hour later the CR50-pre-treated cells were co-cultured with a Reelin negative BMSC line (HS-5, data not shown). Compared to the control antibody, the addition of CR-50 inhibited H929 cell adhesion to HS-5 cells (Fig. 1A-B) . To examine whether the adhesion of myeloma cells could be improved by Reelin, H929 or U266 cells were pre-incubated (incubated for an hour and then washed) with recombinant Reelin (rReelin) and the cell adhesion to HS-5 cells was measured. As shown in significantly enhanced the adhesion of myeloma cells to BMSCs, whereas the addition of CR-50 in the presence of rReelin suppressed rReelin-mediated cell adhesion. No suppression of adhesion was found in the cells pre-incubated with rReelin and the control antibody (Fig. 1C-D and supplemental Fig. 1A-B) . These results suggest that Reelin promotes MM cell adhesion to BMSCs.
Reelin-mediated MM cell adhesion to BMSCs was further examined by RELN overexpression using the pCrl plasmid (Supplemental Fig. 2A-B) and by knockdown of intrinsic expression using Reelin-specific siRNAs (Supplemental Fig. 2C-D) . As shown in Fig. 2A-B , a significant increase in adhesion to BMSCs was observed in pCrl-transfected H929 cells while a significant decrease in adhesion was found in siRNA-transfected H929 cells. The addition of rReelin to the cells transfected with Reelin-specific siRNAs partially alleviated the inhibition of MM cell adhesion to BMSCs (Fig. 2C-D) . When mutations around the siRNA cleavage site were introduced into Reelin-specific siRNA (m-siRNA1), the knockdown of Reelin expression and the reduction of cell adhesion to BMSCs were both abolished ( Fig. 2C-D , supplemental Fig. 2D ). Similar BMSC-adhesionpromoting role of Reelin was also found in U266 cells (supplemental Fig. 2E-H) . We also compared the expression of several adhesion-related molecules by real time PCR. As shown in Fig. 2E , Reelin overexpression led to the upregulation of essential genes involved in regulating cell adhesion, such as FERMT2 (Kindlin-2), DOCK8, and NRCAM. These results further confirm that Reelin is involved in enhancing MM adhesion to BMSCs.
Reelin promotes MM adhesion via the activation of integrin β1-FAK-Syk-STAT3/Akt pathways
It has been reported that Reelin can activate integrin α3β1 and α5β1 directly or indirectly via inside-out activation (13, 16, 22, (24) (25) (26) . We thus examined whether Reelin promotes MM adhesion to BMSCs via the activation of integrin β1 signaling. As shown in Fig. 3A , integrin β1 staining was positive in H929 cells and was co-localized with the staining of Reelin either in untransfected or pCrl-transfected cells (also seen in supplemental Fig. 3A ). Compared to vector or BSA controls, pCrl transfection or rReelin treatment promoted the activation of integrin β1, resulting in more than 2-fold increase in HUTS-21 + MM cells when co-cultured with BMSCs ( Fig. 3B-C and data not shown). When β1 inhibitory antibody P4C10 was applied to the cell culture, the MM cell adhesion to BMSCs caused by rReelin treatment or Reelin overexpression was abolished ( Fig. 3D-E Previously, we found that Reelin promotes MM cell adhesion to FN by activating integrin β1 signaling pathway including focal adhesion kinase (FAK), Src, integrin-activated spleen tyrosine kinase (Syk), signal transducer and activator of transcription (STAT)3 and Akt (22) . As Reelin-mediated integrin β1 activation was also found in MM cells when co-cultured with BMSCs, we thus examined whether Reelin activates a similar signaling pathway in MM cells in this co-culture system. As shown in Fig. 4A , overexpression of Reelin results in enhanced phosphorylation of FAK (Tyr397), Syk (Tyr525/526), STAT3 (Tyr705), and Akt (Ser473). The addition of Syk inhibitor BAY 61-3606 suppressed the phosphorylation of STAT3 and Akt but not that of FAK, suggesting that Syk phosphorylation is downstream of FAK and is required for STAT3 and Akt activation (Fig. 4B) . The application of PI3K inhibitor LY294002 in the co-culture only inhibited Akt phosphorylation but not the phosphorylation of FAK, Syk, or STAT3, suggesting that PI3K-Akt activation is separate from STAT3 activation and is downstream of FAK and Syk activation (Fig. 4B) . Together, these data indicate that Reelin promotes MM cell adhesion to BMSCs by activating the same integrin β1-FAK-Syk-STAT3/Akt signaling pathways.
ApoER2 is indirectly involved in Reelin-mediated cell adhesion
Although Reelin could bind to α3β1 and α5β1 directly, the binding affinity is much lower than ApoER2 (16, (27) (28) ). An inside-out activation of α5β1 by Reelin was reported via ApoER2 and the intracellular Dab1-Crk/CrkL-C3G-Rap1 pathway (16) . As ApoER2 is expressed in Reelin + H929 cells and partially co-localizes with Reelin ( Fig. 5A and supplemental Fig. 3C ), we wonder whether ApoER2 is involved in Reelin-mediated integrin β1 activation and cell adhesion. Thus, ApoER2 was knocked down in H929 cells by specific siRNAs (Fig. 5B-C) and cell adhesion was examined. Compared to control siRNAs, MM cell adhesion to FN-coated plates (Fig.  5D-F) and HS-5 cells (Fig. 5G-H) were both significantly reduced in MM cells transfected with ApoER2 siRNAs (siRNA2 and siRNA3). This suggests that ApoER2 may be involved in Reelin-mediated cell adhesion.
Unexpectedly, we also observed a down-regulation of Reelin expression in ApoER2 siRNA-transfected MM cells (Fig. 5C ). To examine whether the suppression of MM adhesion by ApoER2 knockdown is due to the inhibition of inside-out activation of integrin β1 or inhibition of Reelin expression, we first measured the activation of key signaling molecule involved in inside-out signaling, C3G (16) . Compared to the control siRNA, the transfection of ApoER2-specific siRNAs suppressed the phosphorylation of C3G, suggesting that ApoER2 may be involved in the activation of C3G signaling pathway (Fig. 6A ). In these ApoER2 siRNAtransfected cells, the co-transfected Reelin-expressing plasmid could overcome ApoER2-siRNA-caused Reelin down-regulation but had minimal effect on the suppression of C3G phosphorylation (Fig. 6B) . While ApoER2 knockdown itself led to a mild reduction in integrin β1 activation and cell adhesion, the co-transfection of ApoER2 siRNAs and Reelin-expressing plasmid resulted in comparable β1 activation and cell adhesion when compared to siRNA controls (Fig. 6C-D) . This suggests that the suppression of MM cell adhesion by ApoER2 siRNA may result from the reduction of Reelin expression, which subsequently affects the activation of integrin. The inside-out activation of integrin induced by Reelin-ApoER2 interaction and C3G phosphorylation may not play a major role in Reelinmediated MM cell adhesion.
It has been reported that the binding of ApoER2 with its ligand resulted in the activation of the zinc-finger transcription factor specificity protein 1 (Sp1) (29) . Activated Sp1 could then bind to RELN promoter region and promote Reelin expression in retinoic acid-treated neuronal NT2 cells (30) . As Sp1 is highly expressed in MM cells (31), we examined whether ApoER2 affects RELN expression in MM cells via Sp1. As shown in Fig. 6E-F , similar patterns of Sp1 and RELN down-regulation were found in ApoER2 siRNA-transfected H929 cells (Fig. 6E-F) . Less Sp1 protein was also found in cells with ApoER2 knockdown (data not shown). When a small molecule, terameprocol (TMP) was used to inhibit Sp1 activity, the Reelin expression was suppressed (Fig.  6G-H) , suggesting that Reelin expression is regulated by Sp1 activity and Sp1 expression is regulated by ApoER2-mediated signaling. 
Discussion
The extracellular matrix protein Reelin plays an important regulatory role on the migration and adhesion of neurons and likely tumor cells. In a pancreatic cancer cell line, Reelin inhibits cell migration via its high affinity receptors ApoER2/VLDLR and intracellular adaptor protein Dab1 (21) . Whether it promotes cell adhesion in tumors has not been thoroughly examined. Our previous study revealed that Reelin could be released from myeloma cells and induced cell adhesion to FN via integrin β1 signaling pathway (22) . Blocking Reelin secretion by Brefeldin A diminished the activation of integrin β1. In this study, we further showed that myeloma cell adhesion to bone marrow stromal cells was also promoted by Reelin. Similar β1/FAK/Src/Syk/STAT3 and Akt signaling pathways were activated in Reelin-dependent but ApoER2-independent manner.
Many surface molecules contribute to the close interaction between myeloma cells and BMSCs, rendering the tumor cells resistant against cytotoxic and apoptotic stimuli (2-6). Among them, FN is a large heterodimeric glycoprotein that can be found on the surface of multiple types of stromal cells as well as plasma and extracellular matrix. It can bind to integrin β1 expressed on tumor cells, facilitating the stromal-tumor interaction (21) . Our previous study indicates that Reelin promotes myeloma cell adhesion to FN-coated plates by activating integrin β1 (22) . The current study shows that the adhesion of myeloma cells to HS-5 cells is also promoted by Reelin via similar β1 signaling pathway. The β1 integrin blockade suppresses Reelin-mediated myeloma cell adhesion not only to FN-coated plates but also to HS-5 cells. It is thus reasonable to suggest that Reelin facilitates the bindng of integrin β1 on myeloma cells to FN on the surface of HS-5 cells. Such myeloma-BMSC interaction subsequently promotes myeloma cell survival and drug resistance in the bone marrow (22, 32) . The function-blocking antibody CR-50 may thus be used as a potential therapeutic agent to suppress myeloma-BMSC interaction and enhance drug resistance of myeloma cells.
Sekine, et al. showed that although Reelin could bind to integrin α5β1 with low affinity, the activation of α5β1 in neurons actually depends on the interaction of Reelin with its high affinity receptor ApoER2 which subsequently activates the intracellular Dab1-Crk/CrkL-C3G-Rap1 pathway (16) . In myeloma cells, however, ApoER2 is not likely involved in Reelin-mediated activation of integrin β1 signaling. First, the transcription of key molecule Dab1 was undetectable (22) . Second, although the knockdown of ApoER2 by siRNA results in reduced phosphorylation of C3G and reduced cell adhesion, it also reduced Reelin expression. The overexpression of Reelin in ApoER2 siRNA-transfected cells alleviated the suppression of β1 activation and cell adhesion but not that of C3G activation. It suggests that ApoER2 expression and C3G phosphorylation is probably not involved in Reelin-mediated cell adhesion. Instead, ApoER2 may indirectly improve cell adhesion via upregulating Reelin expression.
It has been reported that an intracellular fragment of ApoER2 negatively regulates RELN transcription. A γ-secretase activated by the binding of Reelin with ApoER2 was responsible for the cleavage of ApoER2 (33) . Interestingly, our results with ApoER2 knockdown and Sp1 inhibition suggest that ApoER2 promotes the expression and activity of transcription factor Sp1 and thus facilitates RELN transcription in myeloma cells. In addition, a γ-secretase inhibitor N-[N-(3.5-difluorophenacetyl) -L-alanyl]-S-phenyl glycinet-butyl ester (DAPT) did not affect Reelin expression or Reelin-mediated myeloma cell adhesion (data not shown). Whether the disparity of RELN regulation between the two groups is due to the differences in cell types or culture conditions awaits further investigation.
Taken together, our results reveal that Reelin promotes myeloma cell adhesion to bone marrow stromal cells. This process is independent of its high affinity receptor ApoER2. Instead, Reelin activates integrin β1, facilitates its binding with fibronectin on the surface of bone marrow stromal cells, and activates FAK-Syk-STAT3/Akt signaling pathway. The expression of Reelin can be enhanced by ApoER2-mediated Sp1 upregulation. These findings further highlight the therapeutic potential of intervening with the complex interaction of myeloma cells with bone marrow microenvironment by targeting the Reelin/integrin/FAK axis.
Materials and Methods
Cell lines and cell culture
The human myeloma cell line NCI-H929 (shown as H929) and U266 were kindly provided by Prof. Jian Hou from Shanghai Chang Zheng Hospital and Prof. Yu Zhang from Peking University Health Science Center (Beijing, China), respectively. HS-5 was provided by Prof. Yuanzhong Chen from Affiliated Union Hospital of Fujian Medical University. H929 and U266 cells were cultured in RPMI 1640 (GibCo, Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Hyclone, ThermoFisher Scientific, Waltham, MA, USA). HS-5 was cultured in DMEM (GibCo) supplemented with 10% FBS. All the cell cultures were supplemented with 2 mmol/L glutamine and 1% penicillin/ streptomycin (GibCo) and were cultured at 37 °C in a humidified atmosphere of 5% CO2.
Quantitative RT-PCR
Total RNA was isolated from the indicated cells using TRIzol (Invitrogen, Grand Island, NY, USA), according to the manufacturer's instructions. The cDNA was synthesized using the Transcriptor First Strand cDNA Synthesis kit (Tiangen, Beijing, China). Real-time PCR was performed using a PCR Master Mix (Roche, Basel Schweiz, Switzerland) according to the manufacturer's protocol. Quantitative PCR was performed on an iCycler (Bio-Rad Laboratories, Hercules, CA, USA). The primer sequences are shown in Table 1 . The PCR conditions were 94 °C for 12s, 60 °C for 12s, and 72 °C for 12s. The quantification was based on ∆∆CT calculations and was normalized to GAPDH as loading controls. CGAAGAUGAGCUCCAUAUAdTdT
The difference between Reelin siRNA1 and m-siRNA1 is underlined.
Transient transfection
Full-length Reelin expression vector, pCrl, was a generous gift from Prof. Tom Curran (The Children's Hospital of Philadelphia, Philadelphia, PA). pcDNA3 was used as a control vector. siRNAs against RELN and APOER2 were purchased from RIBOBIO (Guangzhou, China). MM cells growing at logarithmic phase were transfected with either 10µg pCrl or control vector pcDNA3, or 300pmol Reelin-(or ApoER2-) specific siRNA, negative control siRNA (siNC), or a specific control siRNA with nucleic acid mutations around the cleavage site (m-siRNA1) using electroporation (Multiporator, Eppendorf, Hamburg, Germany). The sequences of siRNAs were shown in Table 2 .
Cell adhesion assays
HS-5 cells at 2×10 5 cell/ml were allowed to attach to 96-well plates at 37 °C overnight. Plain myeloma cells (H929 or U266 cells) or myeloma cells transfected with plasmid and/or siRNAs 40 hours earlier were labeled with 10 μM calcein-acetoxymethyl ester (Calcein-AM, Life Technologies, Grand Island, NY) for 30 minutes at 37°C and washed for three times. The cells were pre-incubated at 5×10 5 /ml in RPMI1640 with recombinant Reelin protein (1 µg/ml, R&D, Minneapolis, MN, USA) and/or Reelin-specific blocking antibody CR-50 (20 µg/ml, MBL International Corporation, Woburn, MA, USA), and/or the blocking antibody against integrin β1 (P4C10 clone, 20 µg/ml, Merck Millipore, Massachusetts, MA), and/or isotype control (Ctrl) mouse IgG antibodies (20 µg/ml, eBioscience). After 1 hour of pre-incubation at 37 °C, the cells were washed and resuspended at 5×10 5 /ml in RPMI1640 with 0.1% BSA (adhesion medium). The cells were then added in triplicate to HS-5 cells at 37 °C for 1 hour. The unattached cells were removed by three washes with pre-warmed serum-free RPMI 1640 and the attached cells were counted for three microscopic fields (20×) and averaged. A laser-scanning confocal microscope (U-HGLGPS, Olympus, Shinjuku-ku, Tokyo, Japan) was used to distinguish the labeled H929 or U266 cells from unlabeled HS-5 cells.
For FN adhesion assays, a 96-well plate was coated with 40 µg/ml of FN (Sigma-Aldrich, Oakville, ON) in PBS at 4 °C overnight. BSA in PBS (5%) was then used to block nonspecific binding sites in the wells at 37 °C for 1 h before the experiment. Transfected myeloma cells were then added in triplicate to FN-coated 96-well plates at 37 °C for 1 hour, and unbound cells were removed. The attached cell numbers were counted for three microscopic fields (20×) per well and averaged. The attached cells were also stained with crystal violet and measured by colorimetric cell adhesion assay at OD 490 using Multiskan MK3 (ThermoFisher Scientific).
Integrin activation assay
A 96-well plate was seeded with 2×10 5 cell/ml of HS-5 overnight. After washing, myeloma cells transfected with pCrl and/or ApoER2-specific siRNA were cultured in HS-5-seeded plates for 1 hour at 37°C. Myeloma cells were then separated from HS-5 cells by pipetting and stained with anti-CD29-PE (HUTS-21, activated integrin β1, BioLegend, San Diego, CA, USA). The cells were analyzed by FACS Arial II (BD PharMingen, San Diego, CA). To determine the level of nonspecific binding, the cells were stained in parallel with the PE isotype control mouse IgG antibodies (BD PharMingen, San Diego, CA, USA).
Immunoblotting and confocal microscopy
Following incubation under the indicated conditions, including culturing on FN or HS-5-coated plates and addition of DMSO, Syk inhibitor IV BAY 61-3606 (1 µmol/L, Merck Millipore), PI3K inhibitor LY 294002 (50 µmol/L, Cell Signaling Technology, Danvers, MA) or Sp1 inhibitor terameprocol (TMP, Sigma-Aldrich, Oakville, ON), H929 cells transfected with plasmid and/or siRNAs were collected by pipetting and washed twice with ice-cold PBS, and incubated for 10 minutes at 4 °C in Triton X-100 lysis buffer (30 mM Tris-HCl pH7.5, 150 mM NaCl, 25 mM NaF, 1% Triton X-100, 10% glycerol, 2 mM Naorthovanadate). The whole-cell lysates were subjected to 6-8% gradient polyacrylamide gels and transferred to nitrocellulose membrane (Whatman, GE Healthcare Life Sciences, Pittsburgh, PA, USA). The primary antibodies used were anti-Reelin, anti-ApoER2 purchased from Abcam (Cambridge, MA, USA), anti-phospho-C3G (Tyr504), anti-C3G from Santa Cruz, anti-phospho-FAK (Tyr397), anti-FAK, anti-phospho-STAT3 (Tyr705), anti-STAT3, anti-phospho-Syk (Tyr525/526), anti-Syk, antiphospho-Akt (Ser473), anti-Akt, and anti-GAPDH from Cell Signaling Technology. Goat-anti-mouse IRDye 800CW, Goat-anti-rabbit IRDye 800CW (LI-COR Biosciences, Lincoln, NE, USA), anti-mouse IgG HRP conjugate, anti-rabbit IgG HRP conjugate (Promega, Madison, WI, USA) were used as the secondary antibodies. The immunoreactive bands were detected by fluorescence with LiCor Odyssey Gel imaging Scanner or chemiluminescence with ECL detection reagents (ThermoFisher Scientific), and exposed to ImageQuant TM LAS 500 (GE Healthcare Life Sciences).
H929 cells transfected with plasmid and/or siRNAs were cultured on FN-coated plates overnight and stained with mouse anti-Reelin, rabbit anti-ApoER2, rabbit anti-Integrin beta 1 (Abcam), secondary anti-mouse AlexaFluor 488, anti-rabbit AlexaFluor 594 (ZSGB-BIO, Beijing, China) and H33324 (DOJINDO Molecular Technologies). A laser-scanning confocal microscope (TCS SP5, Leica, Germany) was used to assess the distribution and intensity. The objective lens used is HCX PL APO CS 40×. LAS AF was used to process the images.
Statistical analysis
The data were evaluated by Student's t-test. All data are presented as mean ± standard deviation. The following terminology is used to denote the statistical significance: *p<0.05, **p<0.01, ***p<0.005, ns, not statistically significant.
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